BEST-Fluids Statistical Analysis Plan paper has now been published. Read the full articles via the links below:Full-text version at TRIALS journal website (Open Access) or
Author: aktnadmin
A/Prof Andrea Viecelli Awarded ACTA Emerging Leader Investigator
Congratulations to A/Prof Andrea Viecelli who received one of the first Emerging Leader Investigator Awards at the ACTA ASM 2021. This award recognises Andrea’s contributions
International Clinical Trial Day 20 May 2021.
This week on May 20 we celebrate International Clinical Trials Day. This day commemorates the day James Lind started his study to determine the cause
The AKTN response to the covid-19 pandemic
The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the AKTN had
No benefit from drug used to reduce heart disease in kidney patients
A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely
BEST-Fluids study – recruitment complete
We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard